Published in Cancer Res on September 01, 1999
Gastrointestinal stromal tumours: origin and molecular oncology. Nat Rev Cancer (2011) 3.55
Human telomere, oncogenic promoter and 5'-UTR G-quadruplexes: diverse higher order DNA and RNA targets for cancer therapeutics. Nucleic Acids Res (2007) 3.49
Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis. Lancet Oncol (2009) 3.26
KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors. Am J Pathol (2000) 2.99
Structure of an unprecedented G-quadruplex scaffold in the human c-kit promoter. J Am Chem Soc (2007) 2.26
Gastrointestinal stromal tumors in a mouse model by targeted mutation of the Kit receptor tyrosine kinase. Proc Natl Acad Sci U S A (2003) 2.23
KIT mutations are common in incidental gastrointestinal stromal tumors one centimeter or less in size. Am J Pathol (2002) 2.22
Gastrointestinal stromal tumor. World J Surg Oncol (2009) 2.05
Combined surgical and molecular therapy: the gastrointestinal stromal tumor model. Ann Surg (2006) 1.95
Mutations in exons 9 and 13 of KIT gene are rare events in gastrointestinal stromal tumors. A study of 200 cases. Am J Pathol (2000) 1.79
The histopathological differential diagnosis of gastrointestinal stromal tumours. J Clin Pathol (2001) 1.60
Gastrointestinal stromal tumor. J Gastrointest Oncol (2012) 1.57
Neoadjuvant, adjuvant and palliative treatment of gastrointestinal stromal tumours (GIST) with imatinib: a centre-based study of 17 patients. Br J Cancer (2003) 1.44
Gastrointestinal stromal tumors. Gastroenterol Clin North Am (2013) 1.37
The complexity of KIT gene mutations and chromosome rearrangements and their clinical correlation in gastrointestinal stromal (pacemaker cell) tumors. Am J Pathol (2002) 1.33
Association of platelet-derived growth factor receptor alpha mutations with gastric primary site and epithelioid or mixed cell morphology in gastrointestinal stromal tumors. J Mol Diagn (2004) 1.33
Germline-activating mutation in the kinase domain of KIT gene in familial gastrointestinal stromal tumors. Am J Pathol (2000) 1.28
Sequence occurrence and structural uniqueness of a G-quadruplex in the human c-kit promoter. Nucleic Acids Res (2007) 1.24
Late resistance to imatinib therapy in a metastatic gastrointestinal stromal tumour is associated with a second KIT mutation. Br J Cancer (2004) 1.12
Gastrointestinal stromal tumor of the rectum resected by laparoscopic surgery: report of a case. Surg Today (2007) 1.06
Role of F-fluoro-2-deoxyglucose Positron Emission Tomography in Gastric GIST: Predicting Malignant Potential Pre-operatively. J Gastric Cancer (2011) 1.04
Expression and mutation of c-kit gene in gastrointestinal stromal tumors. World J Gastroenterol (2003) 1.02
The location of KIT and PDGFRA gene mutations in gastrointestinal stromal tumours is site and phenotype associated. J Clin Pathol (2005) 1.02
An update on molecular genetics of gastrointestinal stromal tumours. J Clin Pathol (2006) 1.00
Gastrointestinal stromal tumors in a cohort of Chinese patients in Hong Kong. World J Gastroenterol (2006) 1.00
The meaning of the c-kit proto-oncogene product in malignant transformation in human mammary epithelium. Clin Exp Metastasis (2003) 0.99
KIT exon 11 codon 557/558 deletion/insertion mutations define a subset of gastrointestinal stromal tumors with malignant potential. World J Gastroenterol (2008) 0.98
Predicting malignant potential of gastrointestinal stromal tumors using endoscopic ultrasound. Dig Dis Sci (2008) 0.97
Functional and phenotypic studies of two variants of a human mast cell line with a distinct set of mutations in the c-kit proto-oncogene. Immunology (2003) 0.97
KIT gene deletions at the intron 10-exon 11 boundary in GI stromal tumors. J Mol Diagn (2004) 0.96
Paediatric mastocytosis. Arch Dis Child (2002) 0.95
Malignant gastrointestinal stromal tumor of the gallbladder. J Korean Med Sci (2004) 0.95
Prognostic value of KIT mutation in gastrointestinal stromal tumors. World J Gastroenterol (2005) 0.94
The role of mutational analysis of KIT and PDGFRA in gastrointestinal stromal tumors in a clinical setting. J Transl Med (2011) 0.94
Prognosis and predictive value of KIT exon 11 deletion in GISTs. Br J Cancer (2009) 0.92
Tissue microarrays characterise the clinical significance of a VEGF-A protein expression signature in gastrointestinal stromal tumours. Br J Cancer (2007) 0.92
Diagnostic criteria, specific mutations, and genetic predisposition in gastrointestinal stromal tumors. Appl Clin Genet (2010) 0.91
Gastrointestinal stromal tumors: molecular mechanisms and targeted therapies. Patholog Res Int (2011) 0.91
Treatment of gastrointestinal stromal tumor: focus on imatinib mesylate. Ther Clin Risk Manag (2008) 0.90
C-kit gene mutation in human gastrointestinal stromal tumors. World J Gastroenterol (2004) 0.90
Primary large gastrointestinal stromal tumor of the liver: report of a case. Surg Today (2009) 0.90
Canine and human gastrointestinal stromal tumors display similar mutations in c-KIT exon 11. BMC Cancer (2010) 0.88
A novel germline SDHB mutation in a gastrointestinal stromal tumor patient without bona fide features of the Carney-Stratakis dyad. Fam Cancer (2012) 0.87
Gastrointestinal stromal tumours and their response to treatment with the tyrosine kinase inhibitor imatinib. Virchows Arch (2004) 0.87
A rare case of huge gastrointestinal stromal tumor (GIST) of the stomach extending into the posterior mediastinum. Dig Dis Sci (2002) 0.87
Evaluation of the kinase domain of c-KIT in canine cutaneous mast cell tumors. BMC Cancer (2006) 0.86
A case and literature review of complicated gastrointestinal stromal tumors. Gastroenterol Hepatol (N Y) (2008) 0.85
Merkel cell carcinoma: correlation of KIT expression with survival and evaluation of KIT gene mutational status. Hum Pathol (2010) 0.84
Prognostic value of KIT/PDGFRA mutations in gastrointestinal stromal tumors: a meta-analysis. World J Surg Oncol (2014) 0.82
P53 expression is significantly correlated with high risk of malignancy and epithelioid differentiation in GISTs. An immunohistochemical study of 104 cases. BMC Cancer (2008) 0.80
Long-term follow-up in 54 surgically treated patients with gastrointestinal stromal tumours. Langenbecks Arch Surg (2008) 0.80
Extended adjuvant therapy with imatinib in patients with gastrointestinal stromal tumors : recommendations for patient selection, risk assessment, and molecular response monitoring. Mol Diagn Ther (2013) 0.80
Molecular alterations and expression of succinate dehydrogenase complex in wild-type KIT/PDGFRA/BRAF gastrointestinal stromal tumors. Eur J Hum Genet (2012) 0.80
Clinicopathological significance of c-KIT mutation in gastrointestinal stromal tumors: a systematic review and meta-analysis. Sci Rep (2015) 0.79
Mesenchymal tumor of the pancreas: report of a case. Surg Today (2007) 0.79
Frequency of KIT Mutation in Gastrointestinal Stromal Tumors According to Histologic and Immunohistochemical Findings, the First Report from Iran. Iran J Med Sci (2015) 0.79
Prognostic criteria in patients with gastrointestinal stromal tumors: a single center experience retrospective analysis. World J Surg Oncol (2012) 0.78
[Gastrointestinal stromal tumors. A morphologic and molecular genetic independent tumor entity with new therapeutic perspectives]. Pathologe (2003) 0.78
DNA ploidy and c-Kit mutation in gastrointestinal stromal tumors. World J Gastroenterol (2004) 0.77
Extragastrointestinal stromal tumor in a kidney transplant recipient. Clin Exp Nephrol (2011) 0.77
Behavior of advanced gastrointestinal stromal tumor in a patient with von-Recklinghausen disease: Case report. World J Clin Oncol (2013) 0.77
Practical aspects of risk assessment in gastrointestinal stromal tumors. J Gastrointest Cancer (2014) 0.76
Colorectal gastrointestinal stromal tumors: a brief review. Clin Colon Rectal Surg (2006) 0.76
KIT gene mutations in gastrointestinal stromal tumors: more complex than previously recognized? Am J Pathol (2002) 0.76
The Frequency of Mutations in Exon 11 of the c-kit Gene in Patients With Leukemia. Turk J Haematol (2012) 0.75
Expression and prognostic role of molecular markers in 99 KIT-positive gastric stromal tumors in Taiwanese. World J Gastroenterol (2006) 0.75
Gastrointestinal Stromal Tumor: May Mimic Adnexal Mass. Glob J Health Sci (2015) 0.75
Screening of C-kit gene Mutation in Acute Myeloid Leukaemia in Northern India. Iran J Cancer Prev (2012) 0.75
Gastrointestinal stromal tumor and its targeted therapeutics. Chin J Cancer (2011) 0.75
A novel gain of function mutant in C-kit gene and its tumorigenesis in nude mice. World J Gastroenterol (2005) 0.75
A meta-analysis of prognostic value of KIT mutation status in gastrointestinal stromal tumors. Onco Targets Ther (2016) 0.75
A case of gastrointestinal stromal tumor with internal tandem duplication in the 3'-terminal of the KIT juxtamembrane domain. Dig Dis Sci (2005) 0.75
Gastrointestinal stromal tumors: a seldom diagnosed cause of severe anemia. Dig Dis Sci (2005) 0.75
Genetic progression in gastrointestinal stromal tumors: mechanisms and molecular interventions. Oncotarget (2017) 0.75
The transcriptional landscape of the mammalian genome. Science (2005) 37.63
Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs. Nature (2002) 28.79
fastDNAmL: a tool for construction of phylogenetic trees of DNA sequences using maximum likelihood. Comput Appl Biosci (1994) 24.63
Functional annotation of a full-length mouse cDNA collection. Nature (2001) 23.61
Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science (1998) 21.13
Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell (1997) 18.91
Whole genome sequencing of meticillin-resistant Staphylococcus aureus. Lancet (2001) 18.55
Cultures in chimpanzees. Nature (1999) 13.33
Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol Cell (2000) 10.72
Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature (1996) 10.67
A new class of genetic element, staphylococcus cassette chromosome mec, encodes methicillin resistance in Staphylococcus aureus. Antimicrob Agents Chemother (2000) 9.84
Lethal effect of the anti-Fas antibody in mice. Nature (1993) 9.20
A molecular marker for chloroquine-resistant falciparum malaria. N Engl J Med (2001) 9.18
Characterization of avian H5N1 influenza viruses from poultry in Hong Kong. Virology (1998) 7.99
The emergence and evolution of methicillin-resistant Staphylococcus aureus. Trends Microbiol (2001) 7.73
Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev (2001) 7.60
The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature (1998) 7.38
Ohmic conductance through the inwardly rectifying K channel and blocking by internal Mg2+. Nature (1987) 5.44
Biological heterogeneity, including systemic replication in mice, of H5N1 influenza A virus isolates from humans in Hong Kong. J Virol (1999) 5.21
Decrease of mast cells in W/Wv mice and their increase by bone marrow transplantation. Blood (1978) 5.18
Nucleotide sequence divergence and functional constraint in mRNA evolution. Proc Natl Acad Sci U S A (1980) 4.71
Standard steroid treatment for autoimmune pancreatitis. Gut (2009) 4.33
Potential for transmission of avian influenza viruses to pigs. J Gen Virol (1994) 4.24
Affective picture processing: the late positive potential is modulated by motivational relevance. Psychophysiology (2000) 3.84
The erbB gene of avian erythroblastosis virus is a member of the src gene family. Cell (1983) 3.82
Involvement of PIAS1 in the sumoylation of tumor suppressor p53. Mol Cell (2001) 3.56
Genetic organization of the chromosome region surrounding mecA in clinical staphylococcal strains: role of IS431-mediated mecI deletion in expression of resistance in mecA-carrying, low-level methicillin-resistant Staphylococcus haemolyticus. Antimicrob Agents Chemother (2001) 3.39
1-Phosphatidylinositol 3-kinase activity is required for insulin-stimulated glucose transport but not for RAS activation in CHO cells. Proc Natl Acad Sci U S A (1994) 3.37
Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria. Proc Natl Acad Sci U S A (1998) 3.35
Maturational disturbance of chondrocytes in Cbfa1-deficient mice. Dev Dyn (1999) 3.33
The role of influenza A virus hemagglutinin residues 226 and 228 in receptor specificity and host range restriction. J Virol (1998) 3.25
Sialic acid species as a determinant of the host range of influenza A viruses. J Virol (2000) 3.10
Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide. Leukemia (2012) 3.04
Critical contribution of liver natural killer T cells to a murine model of hepatitis. Proc Natl Acad Sci U S A (2000) 3.03
Colorectal tumours and pit pattern. J Clin Pathol (1994) 3.01
Intracellular Na+ activates a K+ channel in mammalian cardiac cells. Nature (1984) 2.85
Parental exposure to x rays and chemicals induces heritable tumours and anomalies in mice. Nature (1982) 2.85
Epidemiology, enteropathogenicity, and classification of Vi.rio parahaemolyticus. J Infect Dis (1965) 2.84
Atypical adenomatous hyperplasia of the lung. Implications for the pathogenesis of peripheral lung adenocarcinoma. Am J Clin Pathol (1999) 2.81
Involvement of phosphoinositide 3-kinase in insulin- or IGF-1-induced membrane ruffling. EMBO J (1994) 2.81
Familial gastrointestinal stromal tumours with germline mutation of the KIT gene. Nat Genet (1998) 2.80
Similarity among the Drosophila (6-4)photolyase, a human photolyase homolog, and the DNA photolyase-blue-light photoreceptor family. Science (1996) 2.74
The tomato DWARF enzyme catalyses C-6 oxidation in brassinosteroid biosynthesis. Proc Natl Acad Sci U S A (1999) 2.72
Transmission of bacteriocinogenicity by conjugation in group D streptococci. Jpn J Microbiol (1973) 2.60
Decreased production of mast cells in S1/S1d anemic mice. Blood (1979) 2.53
Impact of sarcopenia on survival in patients undergoing living donor liver transplantation. Am J Transplant (2013) 2.51
Close association of HLA-Bw51 with Behçet's disease. Arch Ophthalmol (1982) 2.51
Cycloguanil and its parent compound proguanil demonstrate distinct activities against Plasmodium falciparum malaria parasites transformed with human dihydrofolate reductase. Mol Pharmacol (1998) 2.50
Long-term results of balloon-occluded retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy. J Vasc Interv Radiol (2001) 2.43
The evolution of cooperation in a lattice-structured population. J Theor Biol (1997) 2.43
Effect of temporal fluctuation of selection coefficient on gene frequency in a population. Proc Natl Acad Sci U S A (1975) 2.41
Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-xL. Nature (1995) 2.40
Inclusion of the transcervical approach in video-assisted thoracoscopic extended thymectomy (VATET) for myasthenia gravis: a prospective trial. Surg Endosc (2006) 2.39
The Arabidopsis DIMINUTO/DWARF1 gene encodes a protein involved in steroid synthesis. Plant Cell (1998) 2.39
Cbfa1 is a positive regulatory factor in chondrocyte maturation. J Biol Chem (2000) 2.38
Modification of glial-neuronal cell interactions prevents photoreceptor apoptosis during light-induced retinal degeneration. Neuron (2000) 2.38
Insulin-induced phosphorylation and activation of cyclic nucleotide phosphodiesterase 3B by the serine-threonine kinase Akt. Mol Cell Biol (1999) 2.37
Biological and clinical review of stromal tumors in the gastrointestinal tract. Histol Histopathol (2000) 2.36
Isolation of calcium current and its sensitivity to monovalent cations in dialysed ventricular cells of guinea-pig. J Physiol (1984) 2.30
RNA-dependent RNA polymerase activity of the soluble recombinant hepatitis C virus NS5B protein truncated at the C-terminal region. J Biol Chem (1998) 2.29
Cross-coupling reactions of potassium alkyltrifluoroborates with aryl and 1-alkenyl trifluoromethanesulfonates. Org Lett (2001) 2.28
Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. J Am Coll Cardiol (2000) 2.20
Connective tissue growth factor induces the proliferation, migration, and tube formation of vascular endothelial cells in vitro, and angiogenesis in vivo. J Biochem (1999) 2.18
A recombinant hepatitis C virus RNA-dependent RNA polymerase capable of copying the full-length viral RNA. J Virol (1999) 2.16
New graft-implanting method for thoracic aortic aneurysm or dissection with a stented graft. Circulation (1996) 2.14
Transplantation of human tumors in nude mice. J Natl Cancer Inst (1976) 2.13
Primary signet-ring cell carcinoma of the lung: histochemical and immunohistochemical characterization. Hum Pathol (1999) 2.07
Pathogen invasion and host extinction in lattice structured populations. J Math Biol (1994) 2.05
Genetically mast-cell-deficient W/Wv and Sl/Sld mice. Their value for the analysis of the roles of mast cells in biologic responses in vivo. Am J Pathol (1987) 2.05
Clinical features of a new disease concept, IgG4-related thyroiditis. Scand J Rheumatol (2013) 2.05
Production of adiponectin, an anti-inflammatory protein, in mesenteric adipose tissue in Crohn's disease. Gut (2005) 2.03
Predominant expression of invariant V alpha 14+ TCR alpha chain in NK1.1+ T cell populations. Int Immunol (1995) 2.02
Total cavopulmonary shunt operation in complex cardiac anomalies. A new operation. J Thorac Cardiovasc Surg (1984) 2.01
Characterization of a fission yeast SUMO-1 homologue, pmt3p, required for multiple nuclear events, including the control of telomere length and chromosome segregation. Mol Cell Biol (1999) 1.97
Changes in brain morphology in Alzheimer disease and normal aging: is Alzheimer disease an exaggerated aging process? AJNR Am J Neuroradiol (2001) 1.97
Skeletal muscle pathology in X chromosome-linked muscular dystrophy (mdx) mouse. Acta Neuropathol (1986) 1.97
Interleukin 4 as an essential factor for in vitro clonal growth of murine connective tissue-type mast cells. J Exp Med (1987) 1.96
Evolutionarily stable mutation rate in a periodically changing environment. Genetics (1989) 1.96
A new avian erythroblastosis virus, AEV-H, carries erbB gene responsible for the induction of both erythroblastosis and sarcomas. Cell (1983) 1.95
Upregulation of two death pathways of perforin/granzyme and FasL/Fas in septic acute respiratory distress syndrome. Am J Respir Crit Care Med (2000) 1.94
Microviscosity and order in the hydrocarbon region of phospholipid and phospholipid-cholesterol dispersions determined with fluorescent probes. Biochemistry (1973) 1.94
Acetoacetate metabolism in infant and adult rat brain in vitro. Biochem J (1970) 1.93
Role of alveolar macrophages in initiation and regulation of inflammation in Pseudomonas aeruginosa pneumonia. Infect Immun (1998) 1.92
Bcl-2 prevents apoptotic mitochondrial dysfunction by regulating proton flux. Proc Natl Acad Sci U S A (1998) 1.92
Role of osteopontin in bone remodeling caused by mechanical stress. J Bone Miner Res (1999) 1.92
Interleukin-3 and bryostatin-1 mediate hyperphosphorylation of BCL2 alpha in association with suppression of apoptosis. J Biol Chem (1994) 1.91
High incidence of ultraviolet-B-or chemical-carcinogen-induced skin tumours in mice lacking the xeroderma pigmentosum group A gene. Nature (1995) 1.91
Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF. J Clin Invest (2000) 1.90